Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00229996 · ClinicalTrials.gov registry record · Phase 3
Medical Treatment of Endometriosis-Associated Pelvic Pain
A Phase 3 study of Endometriosis and Pelvic Pain, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- Completed
- Registry status
- Phase 3
- Development phase
- 194
- Enrollment target
- 1
- Study location
NCT00229996 is a Phase 3 study of Endometriosis and Pelvic Pain that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 194 participants, below the 260-participant average among 48 other Endometriosis trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00229996, a Phase 3 study of Endometriosis and Pelvic Pain, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 194 participants
- Enrollment target
- 1
- Study location
Study Summary
The Specific Aim of this project is to compare the efficacy and cost-effectiveness of continuous oral contraceptives versus leuprolide/norethindrone in the treatment of endometriosis-associated chronic pelvic pain. This comparison will be based on a randomized, double-blind, trial of women with chronic pelvic pain who have been diagnosed with endometriosis at the time of surgery within the last 3 years. We hypothesize that, over a 12-month period of postoperative treatment, the efficacy of oral contraceptives is no worse than leuprolide/norethindrone, and that treatment with oral contraceptives is more cost-effective.
Conditions Studied
Interventions
- DRUG Oral Contraceptive
- DRUG Depot-Leuprolide/Norethindrone
Study Locations (1)
Massachusetts
- Brigham and Womens Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2004-07 |
| Phase | Phase 3 |
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)305 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00229996
The ClinicalTrials.gov registry entry for NCT00229996 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 194 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 260-participant average among 48 other Endometriosis trials with a reported enrollment target (25% lower). The listed sponsor is Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Endometriosis appearing as the primary indexed condition, and to 2 interventions - of which Oral Contraceptive is the first listed.
NCT00229996 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00229996 about?
NCT00229996 is a clinical study titled "Medical Treatment of Endometriosis-Associated Pelvic Pain". The Specific Aim of this project is to compare the efficacy and cost-effectiveness of continuous oral contraceptives versus leuprolide/norethindrone in the treatment of endometriosis-associated chronic pelvic pain. This comparison will be based on a randomized, double-blind, trial of women with chro...
What is the current status of trial NCT00229996?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 194 participants. The study started on 2004-07.
What conditions does trial NCT00229996 study?
This clinical trial studies the following conditions: Endometriosis, Pelvic Pain.
What interventions are being tested in trial NCT00229996?
The interventions under investigation include: Oral Contraceptive (DRUG), Depot-Leuprolide/Norethindrone (DRUG).
Who is sponsoring clinical trial NCT00229996?
This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00229996 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometriosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp
RECRUITING · Phase 3
-
Estradiol-mediated Inflammation and Central Sensitization in the Pathophysiology of Endometriosis-associated Pelvic Pain
RECRUITING · Phase 3
-
The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled Trial
RECRUITING · Phase 3
-
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
RECRUITING · Phase 3
-
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain
ACTIVE NOT RECRUITING · Phase 3
-
SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.